ECS Botanics Holdings Ltd (ASX:ECS)

Market Cap	8.81M -2.9%
Revenue (ttm)	21.02M +8.5%
Net Income	-1.91M
EPS	-0.00
Shares Out	1.60B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	76,666
Open	0.0050
Previous Close	0.0055
Day's Range	0.0050 - 0.0050
52-Week Range	0.0030 - 0.0100
Beta	1.14
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 26, 2026

About ECS Botanics Holdings

ECS Botanics Holdings Ltd engages in the cultivation, manufacture, and sale of medicinal cannabis products in Australia and internationally. It is involved in the agriculture business. ECS Botanics Holdings Ltd was founded in 2018 and is headquartered in Subiaco, Australia.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2018
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: ECS

Financial Performance

In fiscal year 2026, ECS Botanics Holdings's revenue was 21.02 million, an increase of 8.55% compared to the previous year's 19.36 million. Losses were -1.91 million, -66.77% less than in 2025.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 1, 2026

Data Sources Report a data error